Clinical trial
Immune Response Following COVID-19 Vaccination (IFVAC)
NCT04736524 is registered in ClinicalTrials.gov with Texas Cardiac Arrhythmia Research Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immune Response Following COVID-19 Vaccination (IFVAC)
- Lead sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 15, 2021
- Completion date
- March 31, 2022
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
igm and igg in blood